Subcellular Distribution of p53 by the p53-Responsive lncRNA NBAT1 Determines Chemotherapeutic Response in Neuroblastoma
- 28 December 2020
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 81 (6), 1457-1471
- https://doi.org/10.1158/0008-5472.can-19-3499
Abstract
Neuroblastoma has a low mutation rate for the p53 gene. Alternative ways of p53 inactivation have been proposed in neuroblastoma, such as abnormal cytoplasmic accumulation of wild-type p53. However, mechanisms leading to p53 inactivation via cytoplasmic accumulation are not well investigated. Here we show that the neuroblastoma risk-associated locus 6p22.3-derived tumor suppressor NBAT1 is a p53-responsive lncRNA that regulates p53 subcellular levels. Low expression of NBAT1 provided resistance to genotoxic drugs by promoting p53 accumulation in cytoplasm and loss from mitochondrial and nuclear compartments. Depletion of NBAT1 altered CRM1 function and contributed to the loss of p53-dependent nuclear gene expression during genotoxic drug treatment. CRM1 inhibition rescued p53-dependent nuclear functions and sensitized NBAT1-depleted cells to genotoxic drugs. Combined inhibition of CRM1 and MDM2 was even more effective in sensitizing aggressive neuroblastoma cells with p53 cytoplasmic accumulation. Thus, our mechanistic studies uncover an NBAT1-dependent CRM1/MDM2-based potential combination therapy for high-risk neuroblastoma patients.Other Versions
Funding Information
- Knut and Alice Wallenberg Foundation (KAW2014.0057)
- Swedish Foundation for Strategic Research (RB13–0204)
- Cancerfonden (CAN2018/591)
- Swedish Research Council (2017–02834)
- Barncancerfonden (PR2018–0090)
This publication has 54 references indexed in Scilit:
- Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastomaNature Genetics, 2012
- Comprehensive SNP array study of frequently used neuroblastoma cell lines; copy neutral loss of heterozygosity is common in the cell lines but uncommon in primary tumorsBMC Genomics, 2011
- Integrative genomics identifies LMO1 as a neuroblastoma oncogeneNature, 2010
- High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onsetProceedings of the National Academy of Sciences, 2010
- Defining the Human Deubiquitinating Enzyme Interaction LandscapeCell, 2009
- The Karyopherin proteins, Crm1 and Karyopherin β1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferationInternational Journal of Cancer, 2009
- Inhibition of Thr-55 phosphorylation restores p53 nuclear localization and sensitizes cancer cells to DNA damageProceedings of the National Academy of Sciences, 2008
- Identification of ALK as a major familial neuroblastoma predisposition geneNature, 2008
- Germline Mutations of the Paired–Like Homeobox 2B (PHOX2B) Gene in NeuroblastomaAmerican Journal of Human Genetics, 2004
- ParcCell, 2003